WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brendan M. OmalleySVP General Counsel2025-06-0610,470$6.76
$70.78kSell
Vishwas SeshadriChief Executive Officer2025-06-0650,676$6.76
$342.57kSell
Joseph Walter VazzanoChief Financial Officer2025-06-0617,795$6.76
$120.29kSell
Vishwas SeshadriChief Executive Officer2025-06-01885$6.24
$5.52kSell
Mark AlvinoDirector2025-05-272,000$6.38
$12.76kSell
Mark AlvinoDirector2025-05-168,000$5.68
$45.44kSell
Vishwas SeshadriChief Executive Officer2025-03-3125,000$4.78
$119.50kSell
Joseph Walter VazzanoChief Financial Officer2025-03-14685$5.29
$3.62kSell
Brendan M. OmalleySVP General Counsel2025-03-03181$5.24
$948.44Sell
Mark AlvinoDirector2025-01-294,000$5.38
$21.52kSell

1 of 2

ABEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC28.13%14,390,007$88.64MInsider
Steven H. Rouhandeh27.32%13,977,076$86.10MInsider
Suvretta Capital Management LLC7.20%3,685,503$22.70MInstitution
Nantahala Capital Management LLC6.86%3,509,850$21.62MInstitution
Adage Capital Partners GP LLC6.35%3,249,994$20.02MInsider
Adage Capital Partners GP LLC5.26%2,691,628$16.58MInstitution
Ayer Capital Management LP4.72%2,413,163$14.87MInsider
Western Standard LLC4.46%2,281,199$14.05MInstitution
Vanguard Group Inc3.95%2,020,185$12.44MInstitution
B. Davis Jeffrey3.77%1,926,170$11.87MInsider

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO41.13%58.87%Net SellingNet Selling
RCKT59.15%40.85%Net SellingNet Buying
VSTM46.59%53.41%Net SellingNet Selling
AURA79.28%18.77%Net SellingNet Buying
ATXS80.89%19.11%
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 58.00% institutional shareholders, 83.02% Abeona Therapeutics insiders, and 0.00% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 28.13% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $88.64M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.